ArticleLeukemia & lymphoma2020

Immune impacts of Bruton tyrosine kinase inhibitors in chronic lymphocytic leukemia patients: are we closer to a holy grail?

Sasanka M Handunnetti et al.PubMed ↗Publisher ↗

No numbers read from the abstract.